I 
109TH CONGRESS 
1ST SESSION H. R. 2065
To establish formally the United States Military Cancer Institute, to require 
the Institute to promote the health of members of the Armed Forces 
and their dependents by enhancing cancer research and treatment, to 
provide for a study of the epidemiological causes of cancer among various 
ethnic groups for cancer prevention and early detection efforts, and 
for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 3, 2005
Mr. YOUNG of Florida introduced the following bill; which was referred to the 
Committee on Armed Services 
A BILL 
To establish formally the United States Military Cancer In-
stitute, to require the Institute to promote the health 
of members of the Armed Forces and their dependents 
by enhancing cancer research and treatment, to provide 
for a study of the epidemiological causes of cancer among 
various ethnic groups for cancer prevention and early 
detection efforts, and for other purposes.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘United States Military 
Cancer Institute Act of 2005’’. 
SEC. 2. UNITED STATES MILITARY CANCER INSTITUTE. 
(a) ESTABLISHMENT.—
(1) IN GENERAL.—There is established in the 
Uniformed Services University of the Health 
Sciences (USUHS) the United States Military Can-
cer Institute (USMCI). 
(2) SCIENTISTS.—The staff of the Institute 
shall include clinical and basic scientists in the De-
partment of Defense who have an expertise in re-
search, patient care, and education relating to oncol-
ogy and who meet applicable criteria for participa-
tion in the Institute. 
(3) COMPONENTS.—The components of the In-
stitute shall include military treatment and research 
facilities that meet applicable criteria and are des-
ignated by the Director of the Institute as divisions 
of the Institute. 
(b) RESEARCH.—
(1) RESEARCH SUBJECTS.—The Institute shall 
carry out research studies on the following subjects: 
(A) The epidemiological features of cancer, 
including assessments of both the carcinogenic 
effect of genetic and environmental factors and
the disparities in health, inherent or common, 
among populations of various ethnic origins. 
(B) The prevention and early detection of 
cancer. 
(C) Basic, translational, and clinical inves-
tigation matters relating to the subjects de-
scribed in subparagraphs (A) and (B). 
(2) COMPLEMENTARY
RESEARCH
ON
ONCO-
LOGIC NURSING.—The research studies under para-
graph (1) shall include complementary research on 
oncologic nursing. 
(c) COLLABORATIVE RESEARCH.—The Institute shall 
carry out the research studies under subsection (b) in col-
laboration with other cancer research organizations and 
entities, as selected by the Director of the Institute for 
purposes of research studies. 
(d) REPORTS.—
(1) IN
GENERAL.—Not later than one year 
after the date of the enactment of this Act, and an-
nually thereafter, the Director of the Institute shall 
submit to the President of the USUHS a report on 
the results of the research studies carried out under 
subsection (b). 
(2) TRANSMISSION OF REPORT.—Not later than 
60 days after the receipt of a report under para-
graph (1), the President of the USUHS shall trans-
mit such report to Congress.
Æ